U.S. flag

An official website of the United States government

NM_000218.3(KCNQ1):c.421G>A (p.Val141Met) AND Short QT syndrome type 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Dec 1, 2005
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000417071.3

Allele description [Variation Report for NM_000218.3(KCNQ1):c.421G>A (p.Val141Met)]

NM_000218.3(KCNQ1):c.421G>A (p.Val141Met)

Gene:
KCNQ1:potassium voltage-gated channel subfamily Q member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.5
Genomic location:
Preferred name:
NM_000218.3(KCNQ1):c.421G>A (p.Val141Met)
HGVS:
  • NC_000011.10:g.2527962G>A
  • NG_008935.1:g.87972G>A
  • NM_000218.3:c.421G>AMANE SELECT
  • NM_001406836.1:c.421G>A
  • NM_001406837.1:c.151G>A
  • NM_001406838.1:c.421G>A
  • NM_181798.2:c.40G>A
  • NP_000209.2:p.Val141Met
  • NP_000209.2:p.Val141Met
  • NP_001393765.1:p.Val141Met
  • NP_001393766.1:p.Val51Met
  • NP_001393767.1:p.Val141Met
  • NP_861463.1:p.Val14Met
  • NP_861463.1:p.Val14Met
  • LRG_287t1:c.421G>A
  • LRG_287t2:c.40G>A
  • LRG_287:g.87972G>A
  • LRG_287p1:p.Val141Met
  • LRG_287p2:p.Val14Met
  • NC_000011.9:g.2549192G>A
  • NM_000218.2:c.421G>A
  • NM_181798.1:c.40G>A
  • NR_040711.2:n.314G>A
Protein change:
V141M; VAL141MET
Links:
OMIM: 607542.0045; dbSNP: rs199472687
NCBI 1000 Genomes Browser:
rs199472687
Molecular consequence:
  • NM_000218.3:c.421G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406836.1:c.421G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406837.1:c.151G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406838.1:c.421G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_181798.2:c.40G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Short QT syndrome type 2
Identifiers:
MONDO: MONDO:0012313; MedGen: C1865019; Orphanet: 51083; OMIM: 609621

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000494620OMIM
no assertion criteria provided
Pathogenic
(Dec 1, 2005)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.

Hong K, Piper DR, Diaz-Valdecantos A, Brugada J, Oliva A, Burashnikov E, Santos-de-Soto J, Grueso-Montero J, Diaz-Enfante E, Brugada P, Sachse F, Sanguinetti MC, Brugada R.

Cardiovasc Res. 2005 Dec 1;68(3):433-40. Epub 2005 Aug 18.

PubMed [citation]
PMID:
16109388

Short QT syndrome manifesting with neonatal atrial fibrillation and bradycardia.

VillafaƱe J, Fischbach P, Gebauer R.

Cardiology. 2014;128(3):236-40. doi: 10.1159/000360758. Epub 2014 May 9. Review.

PubMed [citation]
PMID:
24818999
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000494620.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

In a female infant with short QT interval, atrial fibrillation, and bradycardia (SQT2; 609621), Hong et al. (2005) identified heterozygosity for a c.421G-A transition in the KCNQ1 gene, resulting in a val141-to-met (V141M) substitution within transmembrane domain S1. Functional analysis in Xenopus oocytes demonstrated that in contrast to wildtype channels, which exhibited a slowly activating and deactivating voltage-dependent and K(+)-selective current, the V141M mutant channel current developed instantly at all voltages tested, consistent with a constitutively open channel.

In 2 unrelated girls with short QT syndrome, AF, and bradycardia, Villafane et al. (2014) identified heterozygosity for the V141M mutation in the KCNQ1 gene.

Using Xenopus oocytes expressing human KCNQ1 in the presence or absence of KCNE1 (176261), Peng et al. (2017) characterized 2 KCNQ1 gain-of-function mutations that cause atrial fibrillation, ser140 to gly (S140G; 607542.0032) and V141M. In the absence of KCNE1, S140G, but not V141M, slowed voltage sensor movement, leading to indirect slowing of current deactivation. Slowing of voltage sensor deactivation by S140G in the absence of KCNE1 was independent of channel opening. When KCNE1 was coexpressed, S140G slowed both current deactivation and voltage sensor movement, whereas V141M slowed current deactivation without slowing voltage sensor movement. Slowing of voltage sensor deactivation by S140G in the presence of KCNE1 was dependent on channel opening. The authors proposed a molecular mechanism underlying the effects of the KCNQ1 mutations on channel gating and suggested that KCNE1 mediates changes in pore movement and voltage sensor-pore coupling to slow channel deactivation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024